跳至主要内容
临床试验/NCT07358637
NCT07358637尚未招募不适用

Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma

Henry Ford Health System0 个研究点目标入组 30 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
Validation of AI-OCT as an accurate method for detecting basal cell carcinomas

研究概览

简要总结

Basal cell carcinomas (BCCs) are the most common human malignancy, affecting about 2 million Americans each year. Mohs micrographic surgery (MMS) removes tissue by sequential excision. Costs for MMS could be reduced if the number of necessary excision stages were decreased by a more accurate initial tumor margin assessment.

The goal of this observational study is to learn if Optical Coherence Tomography (OCT) used in conjunction with artificial intelligence algorithms is accurate in the detection of superficial BCC margins prior to MMS. This study also aims to determine if AI-OCT guided margin delineation can reduce the number of stages in MMS.

Researchers will first focus on validating AI-OCT as a method for accurately detecting BCCs. A follow-up study would then address the guided pre-surgical margin delineation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female, ages 18 or older
  • at least one biopsy proven superficial or nodular BCC
  • willingness to have photographs taken of the treatment area
  • ability to understand and willingness to sign a written informed consent document

排除标准

  • infiltrative, micronodular, or morpheaform BCC
  • pregnant women
  • subjects not willing to have a biopsy taken from the treatment area
  • subjects with herpes simplex virus infection in the treatment area

结局指标

主要结局

Validation of AI-OCT as an accurate method for detecting basal cell carcinomas

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David M. Ozog

Principal Investigator

Henry Ford Health System

相似试验